Effect of Vidangadi Guggul comapre with Dhatri Nishe in Madhumeha (Type II Diabetes Mellitus)

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2022/12/048454
• Lead Sponsor: Government Ayurved College and Hospital Nagpur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients who are willing to participate in trial and ready to give written

consent.

2. Patients of type II DM of 30 to 70 years of age, irrespective of sex.

3. Newly detected patients as well as the patient who are not responding to any

oral hypoglycemic agents and blood sugar level is as below of type II DM.

4. Patients with fasting blood sugar ranges from 110-200 mg/dl and post prandial

blood sugar ranges from 180-250 mg/dl, with clinical signs and symptoms of

Madhumeha.

5. Glycosylated hemoglobin (HbA1C) range 6.5 % - 10%.

6. Patient who are diagnosed in routine check-up or present with

other complaints in the hospital.

7. Patient who has not participated in any research project in last 6 months.

8. Patient with controlled hypertension i.e., systolic blood pressure upto140

mm of Hg while diastolic blood pressure up to 100 mm of Hg.

Exclusion Criteria

1. Patients having fasting blood sugar level >200mg/dl and post meal

blood sugar level >250 mg/dl.

2. Patients who are not willing to participate in trial and not ready to give

written consent.

3. Patients having age below 30 and above 70 years.

4. Pregnant women and lactating mothers.

5. Acute complications of hyperglycemia like DKA (Diabetic Ketoacidosis).

6. Type 1 DM, Gestational DM and patient on insulin therapy.

7. Patients suffering from the serious macrovascular and microvascular

complications of DM.

8. Patients suffering from any other serious systemic diseases.

9. Diabetes Mellitus developed due to secondary causes such as infective pancreatitis,

autoimmune pathology etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified